Unstructured abstract
Chromosome 8q gain is associated with poor prognosis. Here, we show that the predictive value of chromosome 8q gain depends on the mutation status and is true for BAP1 but not for SF3B1-mutated tumors.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Henkes foundation (2021-04), Rotterdam, The Netherlands and the Combined Ophthalmic Research Rotterdam (6.2.0), Rotterdam The Netherlands. The funding organizations had no role in the design or conduct of this research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Erasmus MC Medical Center gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The Rotterdam Ocular Melanoma Study Group (ROMS) is a collaborative research group with members from the Rotterdam Eye Hospital, Departments of Ophthalmology, Pathology and Clinical Genetics, of the Erasmus MC, Rotterdam, The Netherlands.
Financial support: This study was funded by the Henkes foundation (2021-04), Rotterdam, The Netherlands and the Combined Ophthalmic Research Rotterdam (6.2.0), Rotterdam The Netherlands. The funding organizations had no role in the design or conduct of this research.
Conflict of interest: no conflicting relationship exists for any author.
Address for reprints: Emine Kilic, Department of Ophthalmology, room Ee1610, Erasmus MC Medical Center, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands
Data Availability
All data produced in the present study are available upon reasonable request to the authors
